IQVIA

ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

Retrieved on: 
Wednesday, November 8, 2023
Patient, FDA, Growth, ANI, Development, Rare disease, EBITDA, Nephrology, GAAP, ACTH, Anders, USP, Purified, CGT, Neurology, Generic, Rheumatology, Bank, Pharmaceutical industry, Video game, Generic drug, IQVIA

-- Generics, Established Brands and Other reported net sales of $102.1 million, representing year-over-year growth of 43.4% --

Key Points: 
  • Nikhil Lalwani, President and CEO of ANI stated, “Strong execution has resulted in another record quarter for revenue and adjusted non-GAAP EBITDA, positioning us to raise full year 2023 guidance for the third consecutive quarter.
  • Third Quarter 2023 Financial Highlights:
    Net revenues were $131.8 million compared to $83.8 million in Q3 2022.
  • Since the launch of Cortrophin Gel, the overall ACTH category has experienced six consecutive quarters of year-over-year growth from second quarter 2022 to third quarter 2023.
  • Sales of generic pharmaceuticals products, established brands and other grew 43.4% year-over-year in the third quarter of 2023.

GENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023

Retrieved on: 
Thursday, November 2, 2023
Transplant, Labcorp, UCSF, American Association for the Study of Liver Diseases, BMI, Hepatology, MD, University of California, MBA, ACLF, PBC, Gubra, NAS, Poster, Division, NASH, GAN, Biopsy, University, CET, Primary biliary cholangitis, FACP, Ipsen, Patient, Abstract, Liver support system, IQVIA, AASLD, Medical device, Pharmaceutical industry, Medical imaging, Euronext, Gastroenterology

Participants include study investigators, principal investigators and other healthcare professionals from the US, France, Germany and the UK.

Key Points: 
  • Participants include study investigators, principal investigators and other healthcare professionals from the US, France, Germany and the UK.
  • Two Patient Advocacy Council sessions will be held on Saturday November 11, 2023.
  • Participants in this event include Dr. Jennifer Lai (MD, MBA, FACP) and the Global Liver Institute.
  • GENFIT will present new data on its NASH diagnostics technology, including:
    The impact of BMI on NIS2+™ and established non-invasive tests for the evaluation of non-alcoholic liver disease (15’ Oral Presentation #238, Pr.

IQVIA’s Christina Mack Named 2023 PharmaVoice 100 Honoree

Retrieved on: 
Monday, November 6, 2023
Data Management, Biotechnology, Technology, Professional Services, Health, Health Technology, Research, Data Analytics, Software, Science, Clinical Trials, NYSE, NBA, IQV, NBA scoring leaders, Industry Dive, National Basketball Association, Nike Vaporfly and Tokyo 2020 Olympics Controversy, Population health, Life, 2020 NBA Bubble, COVID-19, Patient, IQVIA, Management, Nursing

IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, announced that Dr. Christina Mack, chief scientific officer, has been named to the 2023 PharmaVoice 100 list.

Key Points: 
  • IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, announced that Dr. Christina Mack, chief scientific officer, has been named to the 2023 PharmaVoice 100 list.
  • Christina Mack and her fellow honorees inspire advancements by guiding their teams, supporting their patients, and propelling their organizations’ missions forward.
  • We are excited to recognize their contributions through this annual list,” said Meagan Parrish, lead editor of PharmaVoice.
  • The work we do together is pushing new boundaries in science and technology to improve population health and patient outcomes,” said Dr. Mack.

PicnicHealth Announces Three New Advisors and Expands Expertise in Regulatory-ready Research

Retrieved on: 
Monday, November 6, 2023
Software, Research, Professional Services, Pharmaceutical, Data Management, Oncology, Consumer, Technology, Data Analytics, Science, Other Consumer, Biotechnology, Health, Food, Johns Hopkins University, Public health, Life, Registry, Merck, Brody, Acquisition, Regulation of tobacco by the U.S. Food and Drug Administration, Harvard University, Professional degrees of public health, Aetion, UnitedHealth Group, University of North Carolina at Pembroke, Cerner Enviza, Faculty of Management Studies – University of Delhi, Disease, Medicine, Health policy, University, Public, Harvard T.H. Chan School of Public Health, Cancer, Center for Drug Evaluation and Research, Health policy and management, Doctor of Philosophy, IQVIA, Pharmaceutical industry, Management, Psychology, Pharmacovigilance, New York University, Epidemiology

PicnicHealth , a leading patient-centered healthcare evidence generation company, appointed three advisors in clinical research design – Nancy Dreyer, Solomon Iyasu, and Jeremy Brody.

Key Points: 
  • PicnicHealth , a leading patient-centered healthcare evidence generation company, appointed three advisors in clinical research design – Nancy Dreyer, Solomon Iyasu, and Jeremy Brody.
  • These new advisors are joining PicnicHealth in an advisory capacity to support the company’s expansion into regulatory use cases.
  • Dr. Dreyer is an internationally recognized expert in the use of real-world evidence for regulatory purposes.
  • Dr. Dreyer holds a Ph.D. in epidemiology and Master of Public Health from the University of North Carolina, Chapel Hill.

IQVIA Reports Third-Quarter 2023 Results

Retrieved on: 
Wednesday, November 1, 2023
Health, Health Technology, Other Science, Clinical Trials, Research, Science, Biotechnology, Adjustment, DS, NYSE, IQV, EBITDA, Share repurchase, GAAP, Free cash flow, R, TAS, Environment, Growth, COVID, ID, Webcast, Information Holdings Inc., RFP, Rising Medical Solutions, Sustainable Development Solutions Network, Health care, Bookkeeping, Cryptocurrency, Music, IQVIA

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended September 30, 2023.

Key Points: 
  • IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended September 30, 2023.
  • As of September 30, 2023, R&DS contracted backlog, including reimbursed expenses, was $28.8 billion, growing 11.7 percent year-over-year and 10.5 percent at constant currency.
  • IQVIA had $2,592 million of share repurchase authorization remaining as of September 30, 2023.
  • IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its third-quarter 2023 results and its fourth-quarter and full-year 2023 guidance.

EQS-News: EBD Group: The global biopharma community is now actively partnering for BIO-Europe® 2023

Retrieved on: 
Thursday, October 26, 2023
Bayer, Obesity, BIO, Biotechnology Innovation Organization, Pulse, Diving, Partnering, Business, Lead, McKinsey & Company, IQVIA, Fine chemical

MUNICH, GERMANY – October 25, 2023 – The 29th annual BIO-Europe, the premier partnering conference for the global biopharmaceutical industry, is set to take place November 6–8, 2023, in the vibrant city of Munich, Germany.

Key Points: 
  • MUNICH, GERMANY – October 25, 2023 – The 29th annual BIO-Europe, the premier partnering conference for the global biopharmaceutical industry, is set to take place November 6–8, 2023, in the vibrant city of Munich, Germany.
  • Partnering is in full swing with meeting requests having shown an impressive 65% increase compared to last year, while scheduled meetings have surged by a remarkable 93%.
  • BIO-Europe is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Innovation Organization (BIO).
  • For more information, please visit the conference website at: https://informaconnect.com/bioeurope
    Follow BIO-Europe 2023 on X (formerly Twitter) @EBDGroup (hashtag: #BIOEurope) or on LinkedIn .

Sandra Parrish Woodlief Joins CenExel as Chief Marketing and Communications Officer

Retrieved on: 
Thursday, October 19, 2023
Knowledge, Lake City, Life, University of North Carolina at Charlotte, Communications officer, Chapel Hill, Growth, Marketing, University, Mass media, Patient, IQVIA, Management, Communication

Salt Lake City, UT, Oct. 19, 2023 (GLOBE NEWSWIRE) -- CenExel is proud to announce the appointment of Sandra Parrish Woodlief as its new Chief Marketing and Communications Officer.

Key Points: 
  • Salt Lake City, UT, Oct. 19, 2023 (GLOBE NEWSWIRE) -- CenExel is proud to announce the appointment of Sandra Parrish Woodlief as its new Chief Marketing and Communications Officer.
  • Before joining CenExel, Sandra served as Global Head of Marketing at Median Technologies, an innovative medical imaging company.
  • During this time, Sandra held various leadership roles, spearheading marketing initiatives addressing all phases of clinical development and drug commercialization.
  • "I am thrilled to have Sandra Woodlief on board as our Chief Marketing and Communications Officer," said Stuart Goldblatt, CEO of CenExel.

PatientPoint Expands Best-in-Industry Client Strategy, Analytics and Sales Teams

Retrieved on: 
Wednesday, October 25, 2023
Linda, Research, Health, CPG, Physician, Multiple myeloma, Organization, Merck, Multiple Myeloma Research Foundation, Sarli, HCP, DTP, Growth, Enablement, WebMD, Marketing, Genentech, Strategy, DTC, Patient, IQVIA, Wolters Kluwer, Pharmaceutical industry, Indegene

CINCINNATI, Oct. 25, 2023 /PRNewswire/ -- PatientPoint® today announced exciting growth within its client strategy, analytics and sales organizations, further strengthening its best-in-industry team dedicated to amplifying PatientPoint's reach and impact for life sciences and health and wellness brands.

Key Points: 
  • At PatientPoint, Sarli is focused on identifying emerging industry trends, strengthening client engagement and developing case studies to help advance the point-of-care channel.
  • Melanie Spurrier , Vice President, Research and Analytics: Melanie Spurrier brings 20 years of data and analytics and market research expertise to PatientPoint.
  • PatientPoint also continues to expand its Client Sales and Solutions team, recently welcoming these experienced pharmaceutical, health and wellness and media industry sales leaders:
    David Loux , Vice President, Client Solutions: David Loux joins PatientPoint with 15 years of pharmaceutical and healthcare industry sales experience from sales leadership roles at organizations including Indegene, WebMD, Healthcasts and P\S\L Group.
  • "The unrivaled impact PatientPoint delivers to patients, physicians and our client partners starts with our people—and our world-class team is the reason PatientPoint remains the 35-year point-of-care leader," said PatientPoint Chief Client Officer Linda Ruschau.

IQVIA to Provide Sanofi Its Orchestrated Customer Engagement (OCE) Platform in Africa & Middle East

Retrieved on: 
Monday, October 23, 2023
Health, Technology, Software, General Health, Research, Science, OCE, Intelligence, NYSE, Health care, IQV, Consumer Healthcare Products Association, HCP, Senior, Salesforce, CRM, IQVIA, Pharmaceutical industry, Management, Sanofi

IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life sciences industry, today announced that Sanofi will use the IQVIA OCE platform in select countries across Africa and the Middle East.

Key Points: 
  • IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life sciences industry, today announced that Sanofi will use the IQVIA OCE platform in select countries across Africa and the Middle East.
  • IQVIA OCE is a next-generation life sciences commercial platform that connects all customer-facing functions to deliver more personalized and optimized customer experiences.
  • “Sanofi Consumer Healthcare has been using IQVIA in many markets to support our HCP engagement.
  • “IQVIA has a longstanding relationship with Sanofi, and we are delighted to provide our OCE platform for their advanced customer engagement needs,” said Peter Lane, Senior Vice President and General Manager, Africa, Middle East and South Asia, IQVIA.

New York Regional Home Price Decreases Slightly Month Over Month in September

Retrieved on: 
Wednesday, October 18, 2023
Hudson Valley, Sale, MLS, Catskill, IQVIA, Statistics, Condo, County, Real estate

For September 2023, OneKey MLS reported a regional closed median sale price of $630,000, a 0.80% decrease as compared to the $635,000 reported in August 2023.

Key Points: 
  • For September 2023, OneKey MLS reported a regional closed median sale price of $630,000, a 0.80% decrease as compared to the $635,000 reported in August 2023.
  • In a year-over-year comparison, the closed median sale price increased 5.00% from $600,000, reported in September 2022.
  • Four of nine counties reported an increased closed median sale price in a month-over-month comparison, while five counties reported a decreased median sale price.
  • Rockland (-1.40%), Orange (-2.3%), Sullivan (-3.7%), Bronx (-5.80%), and Westchester (-6.8%) Counties reported month-over-month decreases in closed median sale price.